BridgeBio Oncology Therapeutics Inc.
NASDAQ:BBOTBiotechnology
-$0.03 today
- Market cap
- $149.27M
- Beta
- 0.29
- P/E (TTM)
- -1.5
- EPS (TTM)
- -$4.95
Volume 0.37M
Average 0.37M
Balance Sheet
Inspect the capital base behind the business.
Assets
$448.38M
FY 2025 · Annual
+130.6% YoYLiabilities
$37.28M
FY 2025 · Annual
+553.3% YoYEquity
$411.10M
FY 2025 · Annual
+117.8% YoYBalance Sheet
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $52.7M |
| Short-term Investments | $199.6M |
| Receivables | $146.0K |
| Other Current | $14.1M |
| Total Current Assets | $266.5M |
| PP&E (Net) | $3.2M |
| Long-term Investments | $136.7M |
| Other Non-current | $11.2M |
| Total Non-current Assets | $151.1M |
| Total Assets | $417.6M |
Analysis
Selected assets total $417.6M for Latest. The largest visible component is Short-term Investments at $199.6M, about 47.8% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| SC 13G/A | SC 13G/A filing | Nov 13, 2026 | |
| 10-Q | Quarterly report | Nov 10, 2026 | |
| 8-K | Current report | Nov 10, 2026 | |
| 8-K | Current report | Nov 5, 2026 | |
| 4 | Statement of changes in beneficial ownership | Oct 23, 2026 |
How much cash does BBOT have?
BridgeBio Oncology Therapeutics Inc. (BBOT) reported $373.69M in cash and equivalents in fiscal 2025.
How much debt does BBOT carry?
BridgeBio Oncology Therapeutics Inc. (BBOT) reported $2.77M of total debt, with net debt of -$370.92M.
Continue the stock analysis
Jump to another research area for this company.